TelyRx Holdings (TELY) Q2 2026 earnings summary

Executive summary

• Achieved 143% year-over-year revenue growth to $22.7 million for Q2 2026, with recurring revenue making up nearly 70% of the total and growing 23% sequentially to $15.6 million.

• Provides direct-to-consumer, vertically integrated digital pharmacy services, delivering over 500 generic and branded medications across 60+ conditions, with a focus on convenience, transparency, and rapid fulfillment.

• Operates a 100% cash-pay model, bypassing insurance complexities and leveraging regulatory advantages for vertical integration.

• Serves approximately 97% of the U.S. population via two licensed pharmacies in Texas and Florida, with a monthly shipping capacity of 250,000 prescriptions.

• Surpassed one million prescriptions filled since inception, reflecting growing customer trust and recurring business.

Financial highlights

• Revenue grew to $22.7 million, up from $9.3 million in Q2 2025, driven by both recurring and new customers.

• Gross profit increased to $13 million, with gross margin rising to 57% from 54% year-over-year.

• Adjusted EBITDA loss widened to $3.2 million from $900,000, reflecting increased investment in marketing, headcount, and brand.

• Free cash flow was a loss of $6.4 million for the first six months of 2026, compared to a $1.0 million loss in 2025.

• Cash and equivalents stood at $21.7 million as of June 30, 2026.

Outlook and guidance

• Expect foundational investments in marketing, brand, and digital experience to drive operating leverage and improved SG&A margins in the second half of 2026.

• Anticipate continued growth in repeat customer revenue and further scaling of operations with expanded headquarters and pharmacy capacity.

• Targeting a shift toward 35%-40% organic customer acquisition over the medium term, reducing reliance on paid platforms.

• Management expects continued investment in growth, operational efficiency, and customer base expansion.

• Positioned for accelerated, capital-efficient growth through in-house marketing and digital platform scalability.